719 related articles for article (PubMed ID: 29451472)
1. Hepcidin and proinflammatory markers in children with chronic kidney disease: A case-control study
.
Goyal KK; Saha A; Sahi PK; Kaur M; Dubey NK; Goyal P; Upadhayay AD
Clin Nephrol; 2018 May; 89(5):363-370. PubMed ID: 29451472
[TBL] [Abstract][Full Text] [Related]
2. Hepcidin and diabetes are independently related with soluble transferrin receptor levels in chronic dialysis patients.
Belo L; Rocha S; Valente MJ; Coimbra S; Catarino C; Bronze-da-Rocha E; Rocha-Pereira P; do Sameiro-Faria M; Oliveira JG; Madureira J; Fernandes JC; Miranda V; Santos-Silva A
Ren Fail; 2019 Nov; 41(1):662-672. PubMed ID: 31296086
[No Abstract] [Full Text] [Related]
3. Study of anemia in nondialysis dependent chronic kidney disease with special reference to serum hepcidin.
Goyal H; Mohanty S; Sharma M; Rani A
Indian J Nephrol; 2017; 27(1):44-50. PubMed ID: 28182038
[TBL] [Abstract][Full Text] [Related]
4. Serum hepcidin levels in patients with end-stage renal disease on hemodialysis.
Rubab Z; Amin H; Abbas K; Hussain S; Ullah MI; Mohsin S
Saudi J Kidney Dis Transpl; 2015 Jan; 26(1):19-25. PubMed ID: 25579711
[TBL] [Abstract][Full Text] [Related]
5. Hepcidin--a potential novel biomarker for iron status in chronic kidney disease.
Zaritsky J; Young B; Wang HJ; Westerman M; Olbina G; Nemeth E; Ganz T; Rivera S; Nissenson AR; Salusky IB
Clin J Am Soc Nephrol; 2009 Jun; 4(6):1051-6. PubMed ID: 19406957
[TBL] [Abstract][Full Text] [Related]
6. Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial.
Gaillard CA; Bock AH; Carrera F; Eckardt KU; Van Wyck DB; Bansal SS; Cronin M; Meier Y; Larroque S; Roger SD; Macdougall IC
PLoS One; 2016; 11(6):e0157063. PubMed ID: 27276035
[TBL] [Abstract][Full Text] [Related]
7. Association of hepcidin and anemia in early chronic kidney disease.
Sonkar SK; Singh NK; Sonkar GK; Pandey S; Bhosale V; Kumar A; Usman K
Saudi J Kidney Dis Transpl; 2019; 30(2):315-324. PubMed ID: 31031367
[TBL] [Abstract][Full Text] [Related]
8. Serum Hepcidin and Iron Indices Affect Anemia Status Differently According to the Kidney Function of Non-Dialysis Chronic Kidney Disease Patients: Korean Cohort Study For Outcome in Patients with Chronic Kidney Disease (KNOW-CKD).
Lee SW; Kim YH; Chung W; Park SK; Chae DW; Ahn C; Kim YS; Sung SA
Kidney Blood Press Res; 2017; 42(6):1183-1192. PubMed ID: 29227972
[TBL] [Abstract][Full Text] [Related]
9. The relationship of Prohepcidin levels with anemia and inflammatory markers in non-diabetic uremic patients: a controlled study.
Aydin Z; Gursu M; Karadag S; Uzun S; Sumnu A; Doventas Y; Ozturk S; Kazancioglu R
Ren Fail; 2014 Sep; 36(8):1253-7. PubMed ID: 25040737
[TBL] [Abstract][Full Text] [Related]
10. The relation of hepcidin to iron disorders, inflammation and hemoglobin in chronic kidney disease.
Mercadal L; Metzger M; Haymann JP; Thervet E; Boffa JJ; Flamant M; Vrtovsnik F; Houillier P; Froissart M; Stengel B;
PLoS One; 2014; 9(6):e99781. PubMed ID: 24978810
[TBL] [Abstract][Full Text] [Related]
11. Hepcidin/Ferritin Ratios Differ Among Non-Dialyzed Chronic Kidney Disease Patients, and Patients on Hemodialysis and Peritoneal Dialysis.
Niikura T; Maruyama Y; Nakashima S; Matsuo N; Tanno Y; Ohkido I; Yokoyama K; Yamamoto H; Yokoo T
Ther Apher Dial; 2019 Aug; 23(4):341-346. PubMed ID: 30411489
[TBL] [Abstract][Full Text] [Related]
12. Hepcidin-25 concentrations are markedly increased in patients with chronic kidney disease and are inversely correlated with estimated glomerular filtration rates.
Troutt JS; Butterfield AM; Konrad RJ
J Clin Lab Anal; 2013 Nov; 27(6):504-10. PubMed ID: 24218134
[TBL] [Abstract][Full Text] [Related]
13. Hepcidin and GDF-15 are potential biomarkers of iron deficiency anaemia in chronic kidney disease patients in South Africa.
Nalado AM; Olorunfemi G; Dix-Peek T; Dickens C; Khambule L; Snyman T; Paget G; Mahlangu J; Duarte R; George J; Naicker S
BMC Nephrol; 2020 Sep; 21(1):415. PubMed ID: 32993549
[TBL] [Abstract][Full Text] [Related]
14. The relationship between asymptomatic atherosclerosis and hepcidin-25 in chronic kidney disease patients.
Mohamed ON; Mady AM; Sedik MM; Issa AS; Mohamed OM; Abdelhameed NI
Ann Saudi Med; 2023; 43(5):298-308. PubMed ID: 37805814
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow iron distribution, hepcidin, and ferroportin expression in renal anemia.
Bârsan L; Stanciu A; Stancu S; Căpuşă C; Brătescu L; Mandache E; Radu E; Mircescu G
Hematology; 2015 Oct; 20(9):543-52. PubMed ID: 25745821
[TBL] [Abstract][Full Text] [Related]
16. Serum hepcidin levels are associated with serum triglycerides and interleukin-6 concentrations in patients with end-stage renal disease.
Samouilidou E; Pantelias K; Petras D; Tsirpanlis G; Bakirtzi J; Chatzivasileiou G; Tzanatos H; Grapsa E
Ther Apher Dial; 2014 Jun; 18(3):279-83. PubMed ID: 24119290
[TBL] [Abstract][Full Text] [Related]
17. Acute-Phase Proteins and Iron Status in Cats with Chronic Kidney Disease.
Javard R; Grimes C; Bau-Gaudreault L; Dunn M
J Vet Intern Med; 2017 Mar; 31(2):457-464. PubMed ID: 28140480
[TBL] [Abstract][Full Text] [Related]
18. Renal anemia and hydration status in non-dialysis chronic kidney disease: Is there a link?
Hildegard Stancu S; Stanciu A; Lipan M; Capusa C
J Med Life; 2018; 11(4):293-298. PubMed ID: 30894885
[No Abstract] [Full Text] [Related]
19. Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease.
Ueda N; Takasawa K
Nutrients; 2018 Aug; 10(9):. PubMed ID: 30150549
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
